Clinical trial
Epirubicin for the Treatment of Sepsis & Septic Shock
NCT05033808 is registered in ClinicalTrials.gov with Jena University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Epirubicin for the Treatment of Sepsis & Septic Shock
- Lead sponsor
- Jena University Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- October 19, 2022
- Completion date
- December 31, 2024
- Enrollment
- 45 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.